Stock Movers: SK Hynix, Broadcom, Solstice (Podcast)

SK Hynix shares fell after it began marketing an ADR offering for ~17.79M common shares, valuing the deal at about $28B at Friday’s Seoul close, despite a ~260% YTD rally and $1T+ market cap. Broadcom slipped premarket after expanding its custom ASIC deal with Apple through 2031 to support multiple generations of Apple products. Solstice Advanced Materials and Element Solutions rose on reports they are in talks to merge, potentially within the week.

Analysis

The SK Hynix ADR path is a technical overhang more than a fundamental one: a large new float after a massive rerating usually means cheaper hedging, more arbitrage supply, and a temporary ceiling on the local share class. The second-order issue is better liquidity for future capex, which is bullish for AI supply continuity but eventually increases HBM capacity and raises the odds of memory ASP compression over the next 6-18 months. That makes the memory complex a “buy on proof” trade, not a chase, until pricing or lead times re-accelerate.

For AVGO, the market should view the Apple extension as duration, not TAM. The real value is reduced cash-flow uncertainty through 2031 and a deeper switching moat, but the stock likely needs either margin preservation or faster AI networking growth to re-rate materially. The more important competitive read-through is negative for QCOM/QRVO/SWKS: once Apple locks in custom silicon architecture, re-entry becomes harder and the bargaining power shifts further to the co-design incumbent.

SOL/ESI looks like classic specialty-chemicals consolidation where the premium is driven by synergy credibility and financing terms, not strategic transformation. If a deal appears quickly, the arb is in the spread, but execution risk is real because integration in lower-growth materials tends to reprice lower within 1-2 quarters if synergy capture slips. The contrarian risk is that the market treats any announced tie-up as automatic value creation; in this tape, buyers should demand a clean balance sheet and a modest multiple lift to underwrite the move.

Key Decisions for Investors

• Long AVGO vs short SMH for 1-3 months: own the idiosyncratic Apple-duration story while hedging broad semi beta; cut if AVGO underperforms SMH by ~5% or if Apple supplier commentary shows no incremental content gain.
• If SOL/ESI announces definitive terms, consider merger arb only if the implied spread annualizes above 10% with straightforward financing; otherwise stay flat until the agreement document is public.